Skip to content

Clinical trials

Phase 2 Neoplasm Metastasis trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasm Metastasis Phase: Phase 2 Country / region: France Clear all

148 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20033
20041
20053
20066
200710
20083
20099
20105
20118
20125
201312
20148
20157
20166
20174
20184
20195
202011
20215
20225
20233
20245
20258
20267

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed86
Terminated22
Active, not recruiting15
Recruiting13
Unknown status5
Not yet recruiting3
Withdrawn3
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
UNICANCER18
Centre Leon Berard8
GERCOR - Multidisciplinary Oncology Cooperative Group6
Institut Bergonié6
AstraZeneca5
Gustave Roussy, Cancer Campus, Grand Paris5
Institut Curie5
Federation Francophone de Cancerologie Digestive4
ARCAGY/ GINECO GROUP3
Amgen3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasm Metastasis148
Breast Neoplasms32
Neoplasms28
Colorectal Neoplasms21
Recurrence19
Carcinoma, Non-Small-Cell Lung16
Colonic Neoplasms11
Rectal Neoplasms9
Carcinoma, Renal Cell8
Lung Neoplasms7

Trials

Showing 1 to 25 of 148. Each trial links to its page on Pharma Observatory.

48 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.